Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066231
Filing Date
2025-05-08
Accepted
2025-05-07 21:15:42
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20250331.htm   iXBRL 10-Q 1907638
2 EX-10.1 acad-ex10_1.htm EX-10.1 49670
3 EX-31.1 acad-ex31_1.htm EX-31.1 11730
4 EX-31.2 acad-ex31_2.htm EX-31.2 11886
5 EX-32.1 acad-ex32_1.htm EX-32.1 8525
6 EX-32.2 acad-ex32_2.htm EX-32.2 8571
  Complete submission text file 0000950170-25-066231.txt   8094988

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20250331.xsd EX-101.SCH 967191
71 EXTRACTED XBRL INSTANCE DOCUMENT acad-20250331_htm.xml XML 1523669
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 25923479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)